Curriculum vitae

Date Prepared: / 11/09/12
Name: / Roger Bedimo
Office Address: / 4500 South Lancaster Road, 111-D
Dallas, Texas 75216
Work Phone: / 214-857-0397
Work E-Mail: /
Work Fax: / 214-302-1433
Place of Birth: / Douala, Cameroon

Education

Year / Degree
(Honors) / Field of Study
(Thesis advisor for PhDs) / Institution
09/83 to 11/89 / MD (Hon.) / Medicine / University Center for Health Sciences
University of Yaoundé, Cameroon
09/93 to 05/97 / MS / Parasitology / Tulane University Graduate School
New Orleans, Louisiana

Postdoctoral Training

Year(s) / Titles / Specialty/Discipline
(Lab PI for postdoc research) / Institution
07/98 to 06/01 / Resident / Internal Medicine / Wright State University Medical School, Dayton, Ohio
07/00 to 06/01 / Chief Resident / Internal Medicine / Wright State University Internal Medicine /Dayton VA Medical Center
07/01 to 06/03 / Fellow / Infectious Diseases / University of Alabama at Birmingham, Birmingham, Alabama

Current Licensure and Certification

Licensure

Alabama

Ohio

Board and Other Certification

2001Diplomate, American Board of Internal Medicine

2003Diplomate in Infectious Diseases, ABIM

2011Recertification in Internal Medicine, ABIM

Honors and Awards

Year / Name of Honor/Award / Awarding Organization
2001 / Alpha Omega Alpha / AOA Epsilon Chapter, Wright State University
2001 / Resident of the Year / Wright State University
2001 / Teacher of the Year / Wright State University
2007 / Fellow / American College of Physicians

Faculty Academic Appointments

Year(s) / Academic Title / Department / Academic Institution
2003-2010 / Assistant Professor / Medicine / University of Texas Southwestern
2010-present / Associate Professor / Medicine / University of Texas Southwestern
2005-present / Director, Infectious Diseases Fellowship Training Program / Medicine / University of Texas Southwestern

Appointments at Hospitals/Affiliated Institutions

Past
Year(s) / Position Title / Department/Division / Institution
1990-1993 / District Chief of Public Health / Ministry of Public Health, Cameroon
1996-1998 / Project Coordinator / Medicine/HIV Program Office / LSU Medical Center, New Orleans, Louisiana
2003-2005 / Director, HIV Program / Medicine/Infectious Diseases / VA North Texas Health Care System, Dallas, Texas
Current
Year(s) / Position Title / Department/Division / Institution
2005-present / Section Chief, Infectious Diseases / Medicine/Infectious Diseases / VA North Texas Health Care System, Dallas, Texas

Other Professional Positions

Year(s) / Position Title / Institution
2010-present / AIDS Clinical Trials Group
Clinical Research Site (CRS) Leader / Trinity Health and Wellness Center, Dallas, Texas

Major Administrative/Leadership Positions

Year(s) / Position Title / Institution
2006-present / Course Director, UTSW Annual HIV Update Course and Annual ICAAC/CROI Review / UT Southwestern Medical Center
2005-present / Course Director, Tropical Medicine Senior Elective / UT Southwestern Medical Center
2005-present / Course Director, Infectious Disease Senior Elective / UT Southwestern Medical Center

Committee Service (Member, unless noted otherwise)

Year(s) / Name of Committee / Institution/Organization
UTSW
2006- / Continuous Medical Education Committee / UT Southwestern Medical Center
2011- / Infectious Diseases Division Chief Search Committee / UT Southwestern Medical Center
Hospital
2006- / Continuous Medical Education Committee / VA North Texas Health Care System
2008-2008 / Chair, Continuous Medical Education Committee / VA North Texas Health Care System
State/Regional
None
National/International
2007-present / Core Faculty Member
Member of “Cases On the Web (COW)” Editorial Board / International Antiviral Society – USA
2010-present / Member, Program Committee / HIV Medicine Association (HIVMA) Minority Clinical Fellowship
2011-present / Board of Directors / American Conference for the Treatment of HIV (ACT HIV)
2008-2010 / Treasurer, Executive Committee / VA Specialty Providers in Infectious Diseases (VASPID)
2010-2012 / Secretary, Executive Committee / VASPID
2012-present / Vice-President, Executive Committee / VASPID

Professional Societies

Dates / Society Name, member
2006-present / Member, International AIDS Society – USA
2001-present / Member, The Infectious Disease Society of America
1999-present / Member, The American Medical Association
1998-present / Member, The American College of Physicians
1994-present / Member, The American Society of Tropical Medicine and Hygiene
1994-present / Member, The Royal Society of Tropical Medicine and Hygiene
2007-present / Fellow, the American College of Physicians

Grant Review Activities

Year(s) / Name of Review Committee / Organization
2009-present / Ad-hoc reviewer, CFAR Grants / University of Pennsylvania’s Center for AIDS Research

Editorial Activities

Year(s) / Journal Name
Editor/Associate Editor
None
Editorial Board
None
Ad Hoc Reviewer
AIDS, Journal of AIDS, HIV Medicine, Clinical Infectious Diseases

Grant Support

Present Grant Support
Grantor: Veterans Health Administration (MERIT grant I01 CX000418-01A1)
Title of Project: Rates and determinants of decreased bone health among HIV-infected patients
Role: Principal Investigator
Grant Period: 2011-2015
Annual Amount and date (direct costs only): $150,000 (April 2011)
Total Amount of award (if multi-year) and dates (direct costs only): $600,000 (2011-2015)
Grantor: National Institutes of Health (NIAID) - R03 AG039689
Title of Project: Using VA registry data to estimate age-related risk trajectories for HIV patients.
Role: Co-investigator (Song Zhang, PhD)
Grant Period: 2012-2014
Annual Amount and date (direct costs only): $ 50,000
Total Amount of award (if multi-year) and dates (direct costs only): $ 100,000
Grantor: Veterans Health Administration and Office of Information Technology
Title of Project: Prototype Software for Creating Custom Reports from VistA for Infectious Diseases
Role: Principal Investigator
Grant Period: 2011-2012
Annual Amount and date (direct costs only): $426,200
Total Amount of award (if multi-year) and dates (direct costs only): $426,200
Grantor: National Institutes of Health (NIAID) - U01 AI069471
Title of Project: AIDS Clinical Trials Unit
Role: Site Investigator – Clinical Research Site Leader
Grant Period: 2010-2012
Annual Amount and date (direct costs only): $129,964
Total Amount of award (if multi-year) and dates (direct costs only): $129,964
Grantor: National Institutes of Health (NIAAA) - 52U10 AA13566
Title of Project: Veterans Aging Cohort Study (VACS) / Consortium to improve OutcoMes in hiv/AIDS, Alcohol, Aging, and multi-Substance use (COMpAAAS)
Role: Site Investigator
Grant Period: 2012-2017
Annual Amount and date (direct costs only): $ 192,275
Total Amount of award (if multi-year) and dates (direct costs only): $ 992,275
Past Grant and Contract Support
Grantor: Merck Pharmaceuticals
Title of Project: Evaluation of Safety and Efficacy of Raltegravir and Darunavir Combination in Antiretroviral-Naïve Patients
Role: Principal Investigator
Grant Period: 2009-2011
Annual Amount and date (direct costs only): $177,198
Total Amount of award (if multi-year) and dates (direct costs only): $354,396
Grantor: Tibotec Therapeutics
Title of Project: Evaluation of Safety and Efficacy of Raltegravir and Darunavir Combination in Antiretroviral-Naïve Patients
Role: Principal Investigator
Grant Period: 2009-2011
Annual Amount and date (direct costs only): $68,655
Total Amount of award (if multi-year) and dates (direct costs only): $205,967
Grantor: Federal Drug Administration
Title of Project: Impact of Antiretroviral Therapy on Cardiovascular Disease Risk among HIV-Infected Patients
Role: Principal Investigator
Grant Period: 2011-2012
Annual Amount and date (direct costs only): $59,136
Total Amount of award (if multi-year) and dates (direct costs only): $59,136
Grantor: Abbott Virology
Title of Project: Evaluation of Antiretroviral Regimen Durability in Clinical Setting
Role: Principal Investigator
Grant Period: 2008
Annual Amount and date (direct costs only): $47,500
Total Amount of award (if multi-year) and dates (direct costs only): $47,500
Grantor: Merck Pharmaceuticals
Title of Project: A Study to Evaluate 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults
Role: Site Investigator
Grant Period: 2007
Annual Amount and date (direct costs only): $55,000
Total Amount of award (if multi-year) and dates (direct costs only): $55,000
Grantor: Bristol Myers Squibb Virology
Title of Project: Bone Mineral Density Changes in HIV-Infected Women
Role: Co-Investigator
Grant Period: 2006
Annual Amount and date (direct costs only): $202,650
Total Amount of award (if multi-year) and dates (direct costs only): $202,650

Invited Lectures

Year(s) / Title / Location
International
2005 / Update on Sexually Transmitted Diseases / Mexican Academy of Clinical Pathology National Meeting Monterrey, Mexico
2007 / Treatment Strategies for Drug-Resistant HIV Infection / University of Nuevo Leon
Monterrey, Mexico
2008 / Non-AIDS-Defining Malignancies Among HIV-Infected Patients / University of Nuevo Leon
Monterrey, Mexico
National
2005 / Update on HIV Disease in Africa / American Academy of Physician Assistants Annual Meeting
Orlando, Florida
2006 / HIV-Associated Metabolic Abnormalities / American Academy of Physician Assistants Annual Meeting
San Francisco, California
2008 / Non-AIDS Defining Malignancies Among HIV-Infected Patients / Tulane University
New Orleans, Louisiana
2009 / Invasive Candida Infections / St. Michael’s Hospital
Newark, New Jersey
2009 / Class-Sparing Antiretroviral Regimens / Merck Expert Input Forum
Indianapolis, Indiana
2009 / Cancers in HIV / American Conference for the Treatment of HIV (ACT HIV)
Denver, Colorado
2009 / Cardiovascular Complications of HIV Disease and Antiretroviral Therapy / University of North Carolina at Chapel Hill, North Carolina
2010 / Non-AIDS-Defining Malignancies Among HIV-Infected Patients / American Conference for the Treatment of HIV (ACT HIV)
Denver, Colorado
2010 / Chronic Inflammation in HIV Disease / Merck Expert Input Forum
Dallas, Texas
2011 / Non-AIDS-Defining Malignancies Among HIV-Infected Patients / American Conference for the Treatment of HIV (ACT HIV)
Denver, Colorado
Regional/Local
2005 / Skin, Soft Tissue, Bone and Joint Infections / UT Southwestern Update in Internal Medicine, Dallas, TX
2009 / Skin and Soft Tissue Infections in the Era of MRSA / Southern Medical Society Meeting
Dallas, TX
2010 / HIV, HAART and the Heart / UTS Southwestern Internal Medicine Grand Rounds
2011 / HIV Update from the Conference on Retroviruses and Opportunistic Infections / UT Southwestern Medical Center
Dallas, TX
2011 / Metabolic Complications of HIV Disease / Methodist Hospital Grand Rounds
Dallas, TX
2011 / Metabolic Complications of HIV Disease / Presbyterian Hospital Grand Rounds
Dallas, TX
2011 / Will HIV-Infected Patients Make Old Bones? / UT Southwestern Internal Medicine Grand Rounds
2012 / Selective Pressure of Malaria on Human Genetics / UT Southwestern Global Health Grand Rounds

Technological and Other Scientific Innovations

None

Service to the Community

Member, Mentoring Committee of the C.V. Roman Medical Society, DFW Chapter of the National Medical Association.

Bibliography

Peer-Reviewed Publications

Original Research Articles

  1. Cohen DA, Farley TA, Bedimo R. et al. Cost as a barrier to condom use: the evidence for condom subsidies in the United States. Am J Public Health. 1999;89:567-568
  2. Cohen DA, Nsuami M, Bedimo R et al. a school-based chlamydia control program using DNA amplification technology. Pediatrics. 1998;101:1
  3. Cohen DA, Farley TA, Bedimo JR et al. Implementation of a condom social marketing in Louisiana, 1993 to 1996. Am J Public Health. 1999;89:204-208
  4. Bahebeck J, Bedimo R, Eyenga V, Kouamfack C, Kingue T, Nierenet M, Sosso M.. The management of musculoskeletal infection in HIV carriers. Acta Orthopædica Belgica. 2004;70(4):355-60
  5. Bedimo R, Chen R, Accort N, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989 to 2002. Clin Infect Dis. 2004 Nov 1;39(9):1380-4.
  6. Marinella MA, Burdette SD, Bedimo R, Markert RJ. Leukemoid reactions complicating colitis due to Clostridium difficile. South Med J. 2004 Oct;97(10):959-63.
  7. Bedimo R, Hoesley C, Saag M. Non-AIDS-defining malignancies in the HAART era. Reply to Dal Maso et al. Clin Infect Dis. 2005 Jul 1;41(1):126-127.
  8. Bedimo R, Chen R, Westfall A, Raper J, Allison J and Saag, M. Sustained HIV viral suppression following treatment interruption: an observational study. AIDS Research and Human Retroviruses. 2006 Jan;22(1):40-4.
  9. Bedimo R, Ghurani R, Nsuami M, Turner D, Kvanli M, Brown G, and Margolis D. Lipid abnormalities in HIV/HCV co-infected patients. HIV Medicine, 2006 Nov;7(8):530-6.
  10. Kaur R, Bedimo R, Kvanli M, Turner D, Shaw L, and Margolis D. A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil. AIDS Research and Therapy 2006 May 26;3(1):16.
  11. Busti AJ, Bedimo R, Margolis D, Hardin D. Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated patients after switch to atazanavir/ritonavir (ATV/RTV): A prospective study using hyperinsulinemic, euglycemic clamp testing. Antiv Ther 2006;11:L37.
  12. Cenizal MJ, Skiest D, Luber S, Bedimo R, Davis P, Fox P, Delaney K, Hardy RD. A prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high MRSA prevalence. Antimicrobial Agents and Chemotherapy 2007 Jul;51(7):2628-30.
  13. Morpeth S, Murdoch D, Cabell C, Karchmer A, Pappas P, Levine D, Nacinovich F, Tattevin P, MD; Fernández-Hidalgo N, Dickerman S, Bouza E, del Rio A, Lejko-Zupanc T, de Oliveira A, Iarussi D, Klein J, Chirouze C, Bedimo R, Corey R, Fowler V, and the ICE-PCS Investigators. Non-HACEK* gram-negative bacilli endocarditis: Observations from the International Collaboration on Endocarditis. Annals of Internal Medicine. 18 December 2007;147(12):829-835
  14. Chastain LM, Bain AM, Edwards KL, Bedimo R, Busti AJ. A retrospective study of the lipid lowering efficacy and safety of ezetimibe added to HMG-CoA reductase therapy in HIV-infected patients with hyperlipidemia. Journal of Clinical Lipidology. 2007;1: 634–639
  15. Nguyen ST, Eaton SA, Bain A, Payne K, Rahman A, Bedimo R, Herrington J, Maclayton D, Rodriguez-Barradas M, Busti AJ. The lipid lowering efficacy and safety after a switch to an atazanavir/ritonavir based HAART in HIV-infected patients: a multi-center retrospective study. Pharmacotherapy. 2008 Mar;28(3):323-30.
  16. Rahman AP, Eaton SA, Nguyen, S, Bain AM, Payne K, Bedimo R., and Busti AJ. The safety and efficacy of simvastatin in treating hyperlipidemia in HIV-infected patients on efavirenz-based HAART. Pharmacotherapy 2008;28(3):323–330
  17. Bain AM, Payne KD, Rahman AP, Bedimo R, McClayton D, Rodriguez-Barradas M, and Busti AJ. The lipid-lowering efficacy of switching within non-nucleoside reverse transcriptase inhibitors in HIV-infected patients. American Journal of Infectious Diseases 2008;4 (2): 147-151
  18. Nguyen ST, Bain AM, Bedimo R, Hall RG, Busti AJ. Acute elevation of triglycerides after initiation of fosamprinavir/ritonavir in an HIV-negative patient with baseline hypertriglyceridemia. J Clin Lipidol. 2008 Oct;2(5):398-400. Epub 2008 Jun 26.
  19. Busti AJ, Bedimo R, Margolis DM, Hardin DS. Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir. J Investig Med. 2008 Feb;56(2):539-44
  20. Busti AJ, Bain AM, Hall RG 2nd, Bedimo RJ, Leff RD, Meek C, Mehvar R. Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin. J Cardiovasc Pharmacol. 2008 Jun;51(6):605-10.
  21. Hall RG, Payne K, Bain AM, Rahman A, Nguyen S, Eaton SA, and Bedimo R. Multicenter evaluation of vancomycin dosing – emphasis on obesity. Am J Med. 2008 Jun;121(6):515-8.
  22. Bedimo, RJ. Body-fat abnormalities in patients with HIV: Progress and challenges. Journal of the International Association of Physicians in AIDS Care (JIAPAC) 2008 Nov-Dec;7(6):292-305.
  23. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009 Mar 9;169(5):463-73
  24. Benito N, Miró JM, de Lazzari E, Cabell CH, del Río A, Altclas J, Commerford P, Delahaye F, Dragulescu S, Giamarellou H, Habib G, Kamarulzaman A, Kumar AS, Nacinovich FM, Suter F, Tribouilloy C, Venugopal K, Moreno A, Fowler VG Jr; ICE-PCS (International Collaboration on Endocarditis Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009 May 5;150(9):586-94.
  25. Betts FR, Nucci M, Talwar D, Gareca M, Queiroz-Telles F, Bedimo RJ, Herbrecht R, Ruiz-Palacios G, Young JH, Baddley JW, Strohmaier KM, Tucker KA, Taylor AF, and Kartsonis NA, for the Caspofungin High-Dose study Group. A multicenter, double-blind trial of a high-dose caspofungin regimen versus a standard caspofungin regimen in adult patients with invasive candidiasis. Clinical Infectious Diseases. 2009 Jun 15;48(12):1676-84.
  26. Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC. Incidence of non-AIDS-defining malignancies in HIV-infected vs. non-infected veterans in the HAART era: Impact of immunosuppression. Journal of Acquired Immune Deficiency Syndromes. 2009;52:203-208.
  27. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med 2010,11:462-468.
  28. Bedimo R, Westfall A, Drechsler H, Vidiella G, Tebas P. Abacavir use and Risk of Acute Myocardial Infarction and Cerebrovascular Disease in the HAART era. Clin Infect Dis 2011 Jul;53(1):84-91. PMID: 21653308
  29. Triant VA, Josephson F, Rochester CG, Althoff K, Marcus K, Munk R, Cooper C, D’Agostino RB, Costagliola D, Sabin C, Williams PL, Hughes S, Post W, Chandra-Strobos N, Guaraldi G, Young S, Obenchain R, Bedimo R, Miller V, Strobos J. Adverse Outcome Analyses of Observational Data: Interpretation for Clinical Decision-Making. Clin Infect Dis. 2012 Feb;54(3):408-13. PMID: 22095570
  30. Bedimo R, Kyriakides, T, Brown S, Weidler J, Lie Y, Coakley E, and Holodniy M. Predictive Value of HIV-1 pol Replication Capacity and Phenotypic Susceptibility Scores in Antiretroviral Treatment Experienced Patients. HIV Medicine 2012. Jul;13(6):345-51. PMID: 22276745
  31. Bedimo R, Zhang S, Drechsler H, Maalouf N, and Tebas P. Osteoporotic Fracture Risk Associated with Cumulative Exposure to Tenofovir and Other Antiretroviral Agents. AIDS. 2012.Apr 24;26(7):825-31. PMID: 22301411
  32. Hall RG, Giuliano, CA, Haase KK, Thompson, KA, Frei, CR, Forcade, NA, Brouse SA, Bell T, Bedimo R, and Alvarez CA. Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Infectious Diseases. 2012, 12:104.

Reviews, Chapters, Monographs and Editorials

  1. Bedimo R and Skiest D. Fungal Infections of the Central Nervous System. In Goodkin K, Verma A, Shapshak P (eds.): The Spectrum of neuro-AIDS disorders: pathophysiology, diagnosis, and treatment. American Society for Microbiology (ASM) Press, Washington, DC. 2008.
  2. Bedimo R. Non-AIDS-defining malignancies among HIV-infected patients in the HAART era Current HIV/AIDS Reports. 2008. Curr HIV/AIDS Rep. 2008 Aug;5(3):140-9. PMID: 18627663
  3. Bedimo R. Growth hormone and Tesamorelin in the management of HIV-associated lipodystrophy. HIV/AIDS - Research and Palliative Care. HIV AIDS (Auckl). 2011;3:69-79. Epub 2011 Jul. PMID: 22096409
  4. Bedimo, R. HIV Vaccine Development at the Turn of the 21st Century. The Federal Practitioner. In press.

Books/Textbooks

None

Case Reports

  1. Bedimo R, Weinstein J. Photo quiz. Disseminated blastomycosis. Clin Infect Dis 2001;33:1706, 1770-1.
  2. Bedimo R, Weinstein J. Recurrent extraintestinal Clostridium difficile infection Am J Med 2003;114(9): 770-1.
  3. Bedimo R, Geisler W. Dilantin hypersensitivity syndrome masquerading as fever and systemic illness of unknown origin in an HIV-infected patient. International Journal of STD & AIDS. 2005 Feb;16(2):178-9.
  4. Bridges D, Bedimo R. Severe tuberculosis sepsis in an immunocompetent patient. The American Journal of Medicine. 2006 Mar;119(3):e11-4.

Letters to the Editor